Five cardiovascular comorbidities in five patients were reported after the initiation of GH treatment: three cases of unspecified cardiovascular disease, one case of PVS and one ruptured abdominal aortic aneurysm. This evidence concerns the gene GH1 and cardiovascular disorder.